Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response.
about
Exercise training plus metformin, but not exercise training alone, decreases insulin production and increases insulin clearance in adults with prediabetes.Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.Hepatic and Extrahepatic Insulin Clearance Are Differentially Regulated: Results From a Novel Model-Based Analysis of Intravenous Glucose Tolerance DataThe association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)Novel canine models of obese prediabetes and mild type 2 diabetes.Correlates of insulin clearance in apparently healthy non-obese Japanese men.The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose toleranceConsistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA.Visceral fat and adiponectin: associations with insulin resistance are tissue-specific in women.Diets high in protein or saturated fat do not affect insulin sensitivity or plasma concentrations of lipids and lipoproteins in overweight and obese adults.Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levelsShort-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission.Endurance training inhibits insulin clearance and IDE expression in Swiss mice.Insulin clearance in obesity.Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin ResistanceInsulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis.Elevated nocturnal NEFA are an early signal for hyperinsulinaemic compensation during diet-induced insulin resistance in dogs.Greater omentectomy improves insulin sensitivity in nonobese dogs.Isoflurane and Sevoflurane Induce Severe Hepatic Insulin Resistance in a Canine ModelInsulin Clearance Is Associated with Hepatic Lipase Activity and Lipid and Adiposity Traits in Mexican Americans.Chronic pulsatile hyperglycemia reduces insulin secretion and increases accumulation of reactive oxygen species in fetal sheep islets.Relationship of insulin sensitivity, insulin secretion, and adiposity with insulin clearance in a multiethnic population: the insulin Resistance Atherosclerosis studyInsulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family StudyBranched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS)Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats.Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver.Single-chain insulins as receptor agonists.Mechanisms of improved glucose handling after metabolic surgery: the big 6.Prevalence and determinants of metabolic syndrome: a cross-sectional survey of general medical outpatient clinics using National Cholesterol Education Program-Adult Treatment Panel III criteria in Botswana.Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlatesComponents of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.Hepatic insulin clearance is closely related to metabolic syndrome componentsMetabolic abnormalities underlying the different prediabetic phenotypes in obese adolescentsCEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).Rapid development of cardiac dysfunction in a canine model of insulin resistance and moderate obesity.Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog.Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation.Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver DiseaseA modified oral sugar test for evaluation of insulin and glucose dynamics in horses
P2860
Q30252438-E1ACF5AE-1655-4ECF-8039-C59021072E28Q30404606-3CE87EE6-77BB-4A72-B378-7A2DA3E97EB9Q31060716-828DA558-F08C-440C-BB42-26FA30711D2EQ33567573-A2A12A96-03B7-49D9-BBD4-22EAA68F2CA8Q33589057-F0AE05CC-8AA4-4626-B12A-91B7CCA9FCFDQ33684485-0BB87AF2-A867-433B-AD8C-63C43FBB2D3CQ33705046-0BB39D11-3973-40DD-ADC3-DA9A8C15DEAFQ33867407-D4802D67-F227-44E4-BCB3-F1BD69826B1EQ33893762-ACCA2384-F438-4A05-930B-9905FDC55E2CQ34330808-CA8D1E06-A21C-422C-92BC-5B1ADE0F4733Q35032441-EA89A319-CE9B-4EDA-AFB1-97DC9BB1DDF7Q35123342-AADCD6B1-6A78-4325-8105-C3C280C98876Q35589856-A13F3590-807F-41C0-BE31-54E9EE01DB18Q35611170-8F48A6DF-FC90-4DFC-A979-E1474AEB81FDQ35881723-DADD05C1-0B29-42C6-B119-C312F5944BA6Q36080938-69071E52-D253-48A1-8FE0-9B4A5E34DD42Q36113667-8BBC5F1A-5FEE-4796-BADB-79E429FCC77DQ36157924-2EEF6E4C-9B18-481B-AAC9-6750B42C3200Q36179228-D534DAA2-58D4-4686-B037-E0B1280E8EE2Q36192897-48E1B05B-DCB1-4A79-BF7F-9D99582CF658Q36451539-FBA76802-85A5-4F8D-A434-37B72740FE60Q36477862-F0B6D335-FACE-43F9-A38B-F7AAD0B90232Q36720325-EBE02704-6F3A-4668-A621-9DEA043F0502Q36726164-4E04E83A-E477-42DB-82C8-D73B3FB4BDE1Q36846154-92CEE099-8F3A-4B6F-90FF-F86BCFC0AFCDQ36956067-DF8371E5-766D-4930-85A3-BF3F6186E376Q37066877-437C2344-A45D-488B-8BE7-CE0474648D6EQ37176283-FA5E2BE9-12D7-4ABF-A279-02782F0807F4Q37213999-6B09C980-8265-4DCE-9D71-85152136F889Q37225774-FBAA58DC-CBA1-4D26-AF7D-5D5258C28FC8Q37251096-1CABE9A7-0313-441C-9C1B-2AE803EC1149Q37261174-F897416C-83E9-46FB-A260-C5A4A1CD75B6Q37277990-EC0C5DB5-1EAA-45EB-B215-966D13B3A105Q37311220-1965B597-4106-48C4-867F-C526B2F351FCQ37624585-2B576D3C-FAED-4571-A989-83FAEDB85EDEQ37643533-6205FDE9-B57C-4143-8F89-9C975B8D2E8DQ37672590-30E49859-9543-4866-AEA4-7F57110C8969Q37885168-715A319C-FE72-47BC-A085-F12634F8CACAQ39128964-5AE9C563-AC74-4E01-BFAD-1DC13093C370Q39263313-2001CDE3-1609-4D1F-BE80-5A650BF0D591
P2860
Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Longitudinal compensation for ...... d enhanced beta-cell response.
@en
Longitudinal compensation for ...... d enhanced beta-cell response.
@nl
type
label
Longitudinal compensation for ...... d enhanced beta-cell response.
@en
Longitudinal compensation for ...... d enhanced beta-cell response.
@nl
prefLabel
Longitudinal compensation for ...... d enhanced beta-cell response.
@en
Longitudinal compensation for ...... d enhanced beta-cell response.
@nl
P2093
P1433
P1476
Longitudinal compensation for ...... d enhanced beta-cell response.
@en
P2093
Bergman RN
Hamilton-Wessler M
Mittelman SD
Van Citters GW
P304
P356
10.2337/DIABETES.49.12.2116
P407
P577
2000-12-01T00:00:00Z